A novel TGFβR2 splice variant in patient with aortic aneurysm and family history for aortic dissection: a case report

Cecilia Vecoli,Ilenia Foffa,Simona Vittorini,Nicoletta Botto,Augusto Esposito,Sabrina Costa,Valeria Piagneri,Pierluigi Festa,Lamia Ait-Ali
DOI: https://doi.org/10.2217/pme-2023-0135
2024-04-20
Personalized Medicine
Abstract:We report the clinical presentation and genetic screening of a 31-year-old man with dilatation of the aortic root and ascending aorta and a positive family history for aortic dissection and sudden death. A novel heterozygous variant in a splice acceptor site (c.1600-1G>T) of TGFβR2 gene was identified by using a targeted multi-gene panel analysis. Bioinformatics tools predicted that the c.1600-1G>T variant is pathogenic by altering acceptor splice site at − 1 position affecting pre-mRNA splicing. These data confirm that the diverging splicing in the TGF-β pathway genes may be an important process in aneurismal disease and emphasize the utility of genetic sequencing in the identification of high-risk patients for a more patient's management able to improve outcomes and minimize costs for the care of patients with heritable thoracic aortic aneurysm and dissection.
pharmacology & pharmacy
What problem does this paper attempt to address?